PACS Group (PACS) to Release Quarterly Earnings on Wednesday

PACS Group (NYSE:PACS) is anticipated to announce its Q4 2025 results before the market opens on Wednesday, February 25th. Analysts expect PACS Group to post earnings of $0.4642 per share and revenue of $1.3830 billion for the quarter. Investors are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Friday, March 13, 2026 at 4:00 PM ET.

PACS Group Stock Performance

Shares of PACS opened at $40.78 on Tuesday. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.94 and a quick ratio of 0.94. PACS Group has a 12-month low of $7.50 and a 12-month high of $43.08. The business’s fifty day moving average price is $37.83 and its 200 day moving average price is $23.65. The stock has a market capitalization of $6.39 billion, a PE ratio of 38.84, a price-to-earnings-growth ratio of 1.29 and a beta of -0.64.

Institutional Trading of PACS Group

A number of hedge funds and other institutional investors have recently made changes to their positions in PACS. Cubist Systematic Strategies LLC acquired a new stake in shares of PACS Group in the 1st quarter worth approximately $198,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in PACS Group by 6.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 23,280 shares of the company’s stock worth $262,000 after purchasing an additional 1,443 shares in the last quarter. Millennium Management LLC raised its holdings in PACS Group by 68.3% during the first quarter. Millennium Management LLC now owns 859,295 shares of the company’s stock worth $9,658,000 after purchasing an additional 348,743 shares in the last quarter. Jones Financial Companies Lllp acquired a new stake in PACS Group in the first quarter worth approximately $64,000. Finally, Caxton Associates LLP bought a new position in PACS Group during the 1st quarter valued at $163,000.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. Weiss Ratings reiterated a “hold (c-)” rating on shares of PACS Group in a research report on Monday, December 22nd. UBS Group reaffirmed a “buy” rating and issued a $42.00 target price (down from $50.00) on shares of PACS Group in a research report on Thursday, December 18th. Royal Bank Of Canada reissued an “outperform” rating and set a $47.00 price target on shares of PACS Group in a report on Friday, December 19th. Wall Street Zen raised shares of PACS Group from a “hold” rating to a “buy” rating in a report on Sunday, February 15th. Finally, JPMorgan Chase & Co. initiated coverage on shares of PACS Group in a research note on Wednesday, December 17th. They set an “overweight” rating and a $44.00 target price for the company. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $43.25.

PACS Group Company Profile

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.